Once we've restored your levels to where they should be, most people do great with monthly maintenance treatments
After announcing the state would initiate coverage of GLP-1s to combat obesity in September 2022 as part of their state employee health plan, the state reversed course and in January 2025 announced it was opting to end that coverage beginning July 1, 2025
There is a higher chance of damage in digestion, which can cause bloating, or nausea, particularly at high doses
doi: 10.1128/jb.128.1.192-201.1976 120 HellerJ
Separately, phosphorylation of breast cancer type 1 susceptibility protein (BRCA1) was shown to be mediated by active Chk2 for competent HR of DSBs measured by RAD51 foci [207], while RAD51 recruitment was shown to depend on functional BRCA2 [208]
J.GallezotJ.-D.NaganawaM.BiniJ.et al (2019)